This brand name is authorized in United States
The drug QSYMIA contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Phentermine
UNII 0K2I505OTV - PHENTERMINE HYDROCHLORIDE
|
|
|
|
2
Topiramate
UNII 0H73WJJ391 - TOPIRAMATE
|
|
Topiramate is classified as a sulfamate-substituted monosaccharide. The precise mechanism by which topiramate exerts its antiseizure and migraine prophylaxis effects are unknown. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| QSYMIA Extended release capsule | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: US | FDA, National Drug Code | Identifier(s): 62541-201, 62541-202, 62541-203, 62541-204 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
